| abstract |
The present invention relates to an ophthalmic preparation in the form of eye drops based on BDNF (brain-derived neurotrophic factor). The formulation can be administered topically to the intact ocular surface to prevent loss of visual ability and to restore normal visual function, and for neurodegenerative disorders of the retina, optic nerve, lateral knee and visual cortex. Useful in prevention and treatment. |